USA Rare Earth Inc. Class A Common Stock vs 22nd Century Group Inc — how do they compare? USA Rare Earth Inc. Class A Common Stock trades at $10.13 (market cap $4.23B), while 22nd Century Group Inc trades at $0.65 (market cap $475.95K). The key difference: USA Rare Earth Inc. Class A Common Stock is far larger — about 8887.5× 22nd Century Group Inc's market cap, and 22nd Century Group Inc is more actively traded (78,911 versus 13,677,660). Which is the better fit depends on your goals — on Pluang, investors hold USA Rare Earth Inc. Class A Common Stock for 0 Days and 22nd Century Group Inc for 33 Days on average.
| USAR | XXII | |
|---|---|---|
Market Cap | $4.23B | $475.95K |
Volume | 13,677,660 | 78,911 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $33.68 | $483.00 |
52-Week Low | $10.32 | $0.65 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $2.70B | -$3.83M |
Signals from Pluang's Aura AI — not financial advice
USA Rare Earth (USAR) trades at $11.265, down 4.7% today and near its 52-week low, reflecting persistent sector pressure. The company shows severe financial strain with a net income margin of -2,159.3% and negative cash flow from operations, though analyst consensus remains unanimously bullish with a $34.57 price target. Recent news highlights strategic investments in a $1.2 billion South Carolina facility and a $2.8 billion Brazil acquisition to build a mine-to-magnet supply chain, positioning it for long-term growth amid U.S. critical mineral initiatives.
The stock presents high risk due to extreme losses and cash burn but offers speculative upside if government funding and project milestones materialize. Key risks include execution challenges, reliance on future financing, and sector volatility. Investors should weigh the bullish analyst outlook against the company's current financial instability and macroeconomic headwinds affecting rare earth markets.
XXII trades at $0.67, down 7.98% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.06 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives in France and Europe.
Despite analyst optimism (75% buy ratings with $1,240 price target), fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces significant execution risk in commercializing reduced-nicotine tobacco products while navigating regulatory timelines.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
USA Rare Earth is building an integrated rare earth and permanent magnet supply chain spanning mining, metal and alloy production, and magnet manufacturing, with assets including the Round Top heavy rare earth deposit in Texas, a magnet manufacturing facility in Stillwater, Oklahoma, and metal-and-alloy producer Less Common Metals.
Read more on USAR →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →